---
title: "David Klonoff, M.D. | Sutter Health"
url: "https://www.sutterhealth.org/research/investigators/david-klonoff-md-1078064885"
---

1.  [Home](https://www.sutterhealth.org/) /
2.  [Research](https://www.sutterhealth.org/research) /
3.  [Investigators](https://www.sutterhealth.org/research/investigators) /
4.  David Klonoff, M.D.

![David Klonoff, M.D.](https://dyn.mktgcdn.com/p/Xzpp7PftRFMKD9YTQZjkaTaWm-XIkkF2w7bCa6jTfF0/fit=crop,gravity=auto,dpr=2,width=240,height=240)

# David Klonoff, M.D.

Investigator

Dr. David C. Klonoff is an internationally recognized endocrinologist and pioneer in diabetes technology. He serves as Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute at Mills-Peninsula Medical Center and is a Clinical Professor of Medicine at UCSF. Widely regarded as the founder of the diabetes technology field, he established the Diabetes Technology Meeting, the Hospital Diabetes Meeting, and the Diabetes Technology Society. Dr. Klonoff has authored more than 400 scientific publications and led over 130 clinical trials, including the first multicenter outpatient artificial pancreas study. His innovations include the Glycemia Risk Index and major cybersecurity standards for medical devices. His honors include the ADA Outstanding Physician Clinician Award, the FDA Director’s Special Citation, the IEEE Conformity Assessment Award, and recognition as a top 1% U.S. endocrinology researcher. A leader in global policy, digital health, and device safety, he continues to shape the future of diabetes care.

1720 El Camino Real

Burlingame, CA 94010

## Clinical trials

-   Clinical trial
    
    ### [Diabetes I or II Sensor GENESIS](https://www.sutterhealth.org/research/clinical-trials/diabetes-i-or-ii-sensor-genesis-2059410607)
    
    GENESIS: next GENEration Sensor Life Study
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Diabetes KOS Argus Continuing Glucose Monitoring System](https://www.sutterhealth.org/research/clinical-trials/diabetes-kos-argus-continuing-glucose-monitoring-system-2082984362)
    
    Argus 2.0 Adoption Study
    
    **Status:** Coming Soon
    
-   Clinical trial
    
    ### [Diabetes MiniMed™ NMX8-AID System Insulin Pump CIP351 GATEWAY](https://www.sutterhealth.org/research/clinical-trials/diabetes-minimed-nmx8-aid-system-insulin-pump-cip351-gateway-2060811280)
    
    GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Hypothyroidism M21-341 AVANTI](https://www.sutterhealth.org/research/clinical-trials/hypothyroidism-m21-341-avanti-1095733783)
    
    A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Type 1 Diabetes ONWARDS 11](https://www.sutterhealth.org/research/clinical-trials/type-1-diabetes-onwards-11-2032876855)
    
    A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
    
    **Status:** Open to Enrollment
    

Page 1 of 2

```json
{"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]}
```

```json
{"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/investigators/david-klonoff-md-1078064885#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Investigators","item":"https://www.sutterhealth.org/research/investigators"},{"@type":"ListItem","position":4,"name":"David Klonoff, M.D."}]}
```

```json
{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://www.sutterhealth.org/research/investigators/david-klonoff-md-1078064885#profilepage","url":"https://www.sutterhealth.org/research/investigators/david-klonoff-md-1078064885","name":"David Klonoff, M.D.","dateModified":"2026-06-03","breadcrumb":{"@id":"https://www.sutterhealth.org/research/investigators/david-klonoff-md-1078064885#breadcrumblist"},"primaryImageOfPage":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/Xzpp7PftRFMKD9YTQZjkaTaWm-XIkkF2w7bCa6jTfF0/191x191.webp","width":191,"height":191},"mainEntity":{"@id":"https://www.sutterhealth.org/research/investigators/david-klonoff-md-1078064885"}}
```

```json
{"@context":"https://schema.org","@type":"Person","@id":"https://www.sutterhealth.org/research/investigators/david-klonoff-md-1078064885","name":"David Klonoff, M.D.","givenName":"David","familyName":"Klonoff","honorificSuffix":"M.D.","description":"Dr. David C. Klonoff is an internationally recognized endocrinologist and pioneer in diabetes technology. He serves as Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute at Mills-Peninsula Medical Center and is a Clinical Professor of Medicine at UCSF. Widely regarded as the founder of the diabetes technology field, he established the Diabetes Technology Meeting, the Hospital Diabetes Meeting, and the Diabetes Technology Society. Dr. Klonoff has authored more than 400 scientific publications and led over 130 clinical trials, including the first multicenter outpatient artificial pancreas study. His innovations include the Glycemia Risk Index and major cybersecurity standards for medical devices. His honors include the ADA Outstanding Physician Clinician Award, the FDA Director’s Special Citation, the IEEE Conformity Assessment Award, and recognition as a top 1% U.S. endocrinology researcher. A leader in global policy, digital health, and device safety, he continues to shape the future of diabetes care.","image":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/Xzpp7PftRFMKD9YTQZjkaTaWm-XIkkF2w7bCa6jTfF0/191x191.webp","representativeOfPage":true},"address":{"@type":"PostalAddress","streetAddress":"1720 El Camino Real","addressLocality":"Burlingame","addressRegion":"CA","postalCode":"94010","addressCountry":"US"},"affiliation":{"@id":"https://www.sutterhealth.org/#medicalorganization"},"mainEntityOfPage":{"@id":"https://www.sutterhealth.org/research/investigators/david-klonoff-md-1078064885#profilepage"}}
```
